Inhaled Corticosteroids Can Heighten Risk of Diabetes

Wed, 15 Dec 2010
Despite the fact that inhaled corticosteriods are commonly used for treatment of asthma and chronic obstructive pulmonary disorder, these drugs are related to the progression of diabetes development.

Researchers discovered that inhaled corticosteroids are associated with a 34 per cent increase in the rate of diabetes onset as well as in the rate of diabetes progression.

Moreover, the highest inhaled doses increases the risk of diabetes by 64 per cent and diabetes progression by 54 per cent.

As COPD and diabetes can be age related, it is especially important to explore any potential interaction between inhaled corticosteroid use and degeneration of glycaemic control .

Nearly patients with respiratory diseases were studied, from Quebec health insurance databases.

30,167 had become diabetic during the 5.5 years of follow-up and another 2099 diabetics were studied, who had progressed from oral hypoglycemic treatment to insulin .

Link to this page

Copy and Paste the following HTML into your page.